Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Psychosocial Treatment of Depression in Parkinson's Disease [NA]
An update on a clinical trial evaluating psychosocial treatment for depression in Parkinson's disease.
-
CLINICAL_TRIALS research · 2012-11-16Clinical Trial Update: Investigation of Road-crossing Safety Before and After Training Between Parkinson Disease Pedestrians and Older Pedestrians [NA]
A clinical trial evaluating road-crossing safety training for pedestrians with Parkinson's disease compared to older adults.
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Transcranial Magnetic Stimulation to Treat Parkinson's Disease [Phase 1, Phase 2]
This document reports a completed Phase 1/2 clinical trial evaluating transcranial magnetic stimulation as a treatment for Parkinson disease…
-
CLINICAL_TRIALS research · 2012-11-08Clinical Trial Update: Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Study Protocol [NA]
This document outlines a study protocol for a gait training program combined with executive function tasks in individuals with Parkinson's d…
-
CLINICAL_TRIALS research · 2012-11-08Clinical Trial Update: Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled Trial [NA]
A randomized controlled trial protocol evaluating gait training with executive function tasks in Parkinson's disease; the current status is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-11-06Clinical Trial Update: Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon [NA]
The ramelteon trial for sleep/wake disturbances in basal ganglia disorders has been withdrawn, involving Huntington's disease and Parkinson'…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 [Phase 2]
Phase 2 trial evaluating neuroprotection with CoQ10 and GPI-1485 in Parkinson disease has completed.
-
FDA approval · 2012-10-31FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS research · 2012-10-29Clinical Trial Update: Imaging in the Diagnosis of Parkinson's Disease and Essential Tremor
This clinical trial update discusses ongoing imaging research for diagnosing Parkinson's disease and essential tremor, sponsored by Hospital…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia [Phase 2]
Phase 2 trial comparing an implanted neuroprosthesis with sensory training to improve airway protection in chronic dysphagia; results were p…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions [Phase 1]
A Phase 1 bioequivalence study comparing Lupin's ropinirole hydrochloride CR 2 mg tablets to GlaxoSmithKline's REQUIP XL under fed condition…
-
FDA approval · 2012-10-26FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Pramipexole dihydrochloride as a generic product, manufactured by Aurobindo Pharma Limited, for th…
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease. [Phase 4]
Phase 4 clinical trial evaluating methylphenidate for non-motor symptoms and postural control in Parkinson's disease has been terminated.
-
CLINICAL_TRIALS research · 2012-10-18Clinical Trial Update: Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical Trial
This document describes a continuation treatment protocol for patients who participated in the Adagio TVP 1012/501 Parkinson's trial.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan [Phase 2]
A Phase 2 controlled study of ONO-2506PO in Parkinson's disease patients in Japan has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease [NA]
A terminated clinical trial investigated whether exercise training improves gait and quality of life in people with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease [Phase 4]
Phase 4 multicenter placebo-controlled trial evaluating the effect of rasagiline on sleep-wake disturbances in Parkinson's disease; the stud…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Exercise for People With Parkinson's Disease [Phase 2]
Phase 2 trial evaluating exercise for Parkinson's disease has completed.
-
EMA withdrawal · 2012-09-27EMA Withdrawn: Rivastigmine Teva (rivastigmine) — Teva Pharma B.V.
The EMA withdrew Rivastigmine Teva (rivastigmine) from its European market authorization.
-
CLINICAL_TRIALS research · 2012-09-27Clinical Trial Update: Research of Biomarkers in Parkinson Disease
A completed clinical trial evaluating biomarkers in Parkinson disease and related parkinsonian conditions.
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease [Phase 2]
Phase IIa multicentre study of VR040 in Parkinson's disease has completed.
-
FDA approval · 2012-09-20FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited, marking the entry of a generic …
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE [Phase 1, Phase 2]
A clinical trial update outlines an evaluation of CJH1 (CLR4001) for Parkinson's disease across Phase 1 and Phase 2, with the current status…
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease [Phase 2]
A Phase 2 single-centre trial evaluating VR040, an inhaled form of apomorphine, in idiopathic Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease [Phase 2, Phase 3]
This document provides an update on a completed Phase 2/3 clinical trial evaluating the efficacy and safety of deferiprone in Parkinson's di…